We provide a general framework for describing various roles for biomarkers in cancer prevention research (early detection, surrogate endpoint, and cohort identification for primary prevention) and the phases in their evaluation.
|Home | About | Journals | Submit | Contact Us | Français|
Dis Markers. 2004; 20(2): 97–102.
Published online Aug 19, 2004. doi: 10.1155/2004/309391